Updated: May 2026
What Is Tirzepatide? The Complete Guide to the Most Powerful Weight Loss Medication
Tirzepatide is a dual-action GLP-1/GIP medication that has changed the weight loss landscape. Sold as Mounjaro® (for diabetes) and Zepbound® (for weight loss), it's shown to help people lose up to 22.5% of their body weight in clinical trials — more than any other GLP-1 medication. This guide explains everything you need to know before starting treatment.
Up to 22.5%
Body weight loss
Once Weekly
Single injection
FDA-Approved
Zepbound & Mounjaro
How Does Tirzepatide Work?
What makes tirzepatide unique is its dual-action mechanism. While semaglutide (Ozempic/Wegovy) targets only the GLP-1 receptor, tirzepatide activates both GLP-1 and GIP receptors — two hormones that work together to control appetite and metabolism.
GLP-1 Receptor
› Reduces hunger and appetite
› Slows stomach emptying (feel full longer)
› Lowers blood sugar levels
› Shared with semaglutide
GIP Receptor (Unique to Tirzepatide)
› Enhances fat burning
› Improves insulin sensitivity
› Boosts metabolic efficiency
› Only tirzepatide has this
In simple terms: Tirzepatide makes you feel less hungry, feel full faster, and helps your body burn fat more efficiently — all from a single weekly injection. The dual receptor activation is why clinical trials show it outperforms semaglutide for weight loss.
Tirzepatide Brand Names: Mounjaro vs Zepbound
Tirzepatide is sold under two brand names by Eli Lilly. They're the exact same molecule at the exact same doses — just approved for different conditions:
Mounjaro®
FDA-approved for: Type 2 diabetes
Often prescribed: Off-label for weight loss
Insurance: More likely to be covered (diabetes diagnosis)
List price: $1,079.77/month
Savings card: As low as $25/month
Zepbound®
FDA-approved for: Weight loss (obesity/overweight)
The "official" tirzepatide weight loss drug
Insurance: Limited coverage for weight loss
List price: $1,086.37/month
Also approved for: Obstructive sleep apnea
There's also a third option: Compounded tirzepatide — the same active ingredient prepared by licensed compounding pharmacies at $199-399/month. This is how most people access tirzepatide for weight loss without insurance. See full pricing guide →
How Much Weight Can You Lose on Tirzepatide?
The SURMOUNT clinical trials are the gold standard for tirzepatide weight loss data. Published in the New England Journal of Medicine, they showed remarkable results:
5mg dose
15%
body weight lost
~30 lbs for a 200-lb person
10mg dose
19.5%
body weight lost
~39 lbs for a 200-lb person
15mg dose
22.5%
body weight lost
~45 lbs for a 200-lb person
Source: SURMOUNT-1 trial, New England Journal of Medicine, 2022. Results are averages over 72 weeks with diet and exercise. Individual results vary.
Tirzepatide Dosing Schedule
Tirzepatide follows a gradual titration schedule — starting low and increasing slowly to minimize side effects. Here's the typical progression:
2.5
Weeks 1-4: Starting dose (2.5mg)This is a titration dose — meant to help your body adjust. Weight loss is minimal at this stage.
5.0
Weeks 5-8: First therapeutic dose (5mg)Real appetite suppression begins. Most patients notice reduced hunger and early weight loss.
10
Weeks 9-12+: Mid-range dose (10mg)Stronger appetite control and steady weight loss. Many patients achieve excellent results at this dose.
15
Maximum dose (15mg) — if neededThe highest dose, producing the strongest results (22.5% average loss in trials). Not everyone needs this dose.
Side Effects: What to Expect
Like all GLP-1 medications, tirzepatide can cause side effects — mainly gastrointestinal. The good news: research suggests tirzepatide may have fewer severe GI side effects than semaglutide, despite producing greater weight loss.
Common Side Effects (mild, usually temporary)
› Nausea (most common — typically improves within 2-4 weeks)
› Diarrhea or constipation
› Decreased appetite (expected — it's how the medication works)
› Mild stomach discomfort
› Injection site reactions (minor)
The gradual dosing schedule (starting at 2.5mg and increasing slowly) is specifically designed to minimize these effects. Most patients tolerate tirzepatide well after the initial adjustment period.
For a complete guide including all safety information, see our detailed side effects page →
Who Is Tirzepatide For?
✅ May be right for you if:
› BMI 30+ (obese) OR BMI 27+ with weight-related condition
› You've tried diet and exercise without lasting results
› You have type 2 diabetes AND want weight loss
› You've plateaued on semaglutide
› You want the strongest available GLP-1 option
❌ Not recommended if:
› Personal/family history of medullary thyroid carcinoma
› Multiple endocrine neoplasia syndrome type 2
› Known allergy to tirzepatide
› Pregnant or breastfeeding
› History of pancreatitis
Tirzepatide vs Semaglutide: Quick Comparison
Tirzepatide
✅ Stronger weight loss (15-22%)
✅ Dual-action (GLP-1 + GIP)
✅ Fewer severe GI side effects
✅ FDA-approved for sleep apnea
❌ More expensive
❌ Fewer provider options
Semaglutide
✅ More affordable (from $129/mo)
✅ Oral tablet option available
✅ More providers and competition
✅ Proven heart protection
❌ Lower weight loss (12-17%)
❌ Single-action only
Where to Get Tirzepatide Online
Tirzepatide is available through licensed telehealth providers — no in-person visits required. Both compounded and brand-name options are available depending on the provider.
Frequently Asked Questions About Tirzepatide
What is tirzepatide?
Tirzepatide is a dual-action injectable medication that targets both GLP-1 and GIP hormone receptors. It's FDA-approved as Mounjaro for type 2 diabetes and as Zepbound for weight loss. Clinical trials show it can help patients lose 15-22% of their body weight — making it the most effective GLP-1 medication currently available.
How does tirzepatide work for weight loss?
Tirzepatide works by activating two hormone receptors (GLP-1 and GIP) that regulate appetite, blood sugar, and metabolism. This dual action reduces hunger, slows digestion so you feel full longer, improves insulin sensitivity, and helps your body burn fat more efficiently. It's injected once weekly.
What are the side effects of tirzepatide?
The most common side effects are gastrointestinal: nausea (20-30% of patients), diarrhea, constipation, vomiting, and decreased appetite. These are typically mild to moderate and improve within 2-4 weeks. Serious side effects are rare but include pancreatitis and thyroid concerns — your doctor will screen for risk factors.
How much weight can you lose on tirzepatide?
Clinical trials show average weight loss of 15-22% of body weight over 72 weeks. For a 200-pound person, that's approximately 30-44 pounds. Results depend on dosage, diet, exercise, and individual biology.
How much does tirzepatide cost?
Brand-name Mounjaro/Zepbound costs $1,079-1,086/month without insurance. With insurance, copays can be as low as $25/month. Compounded tirzepatide through telehealth providers costs $199-399/month. See our full cost guide →
Is tirzepatide better than semaglutide?
Tirzepatide produces greater weight loss (15-22% vs 12-17%) and may have fewer severe side effects. However, semaglutide is more affordable and has more provider options. The best choice depends on your budget, insurance, and goals. Read the full comparison →
Who should not take tirzepatide?
Tirzepatide should not be taken by people with a personal or family history of medullary thyroid carcinoma (MTC), multiple endocrine neoplasia syndrome type 2, or a known allergy to tirzepatide. It's not recommended during pregnancy or breastfeeding. Always consult a healthcare provider.
Where can I get tirzepatide online?
Tirzepatide is available through licensed telehealth providers including MEDVi, TrimRx, JRNYS, DirectMeds, SkinnyRx, Eden Telemed, JRNYS, and Ro Body. Both compounded ($199-399/month) and brand-name options are available. Compare all providers →
Ready to Start Tirzepatide?
Compare top-rated providers offering tirzepatide — with current pricing, promotions, and our honest reviews.
Continue Learning
Medical Disclaimer: This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Tirzepatide is a prescription medication that requires evaluation by a licensed healthcare provider. Clinical data referenced is from published peer-reviewed studies (SURMOUNT-1, SURPASS trials, New England Journal of Medicine). Individual results may vary. Compounded medications are not FDA-approved as finished products. Always consult a qualified physician before starting any medication.
